Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11901-020-00521-1 http://scihub22266oqcxt.onion/10.1007/s11901-020-00521-1 32837825!7326530!32837825     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Hepatol+Rep 2020 ; 19 (3): 147-158 Nephropedia Template TP {{tp|p=32837825|t=2020. Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease |pdf=|usr=}}{{32837825}} gab.com Text Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease JO: Curr Hepatol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32837825 #FOAvip PURPOSE OF REVIEW: Albumin administration is recommended to prevent or treat specific complications of decompensated cirrhosis based on its capacity to expand plasma volume. However, the molecule also has many other biological properties that are unrelated to the oncotic activity. The purpose of this review is to examine the hemodynamic and systemic effects of albumin administration in patients with decompensated cirrhosis. RECENT FINDINGS: Besides plasma expansion, albumin appears to act against inflammation, facilitate immunocompetence, and improve cardiac and endothelial function, thus antagonizing critical steps in the pathophysiological cascade underlying decompensated cirrhosis. SUMMARY: Increasing knowledge of the pathophysiological mechanisms of the disease, as well the pleiotropic properties of the molecule, provides the rationale for considering albumin as a multi-target disease-modifying agent in decompensated cirrhosis. Both oncotic and non-oncotic properties likely concur with the clinical benefits of long-term albumin administration recently demonstrated in these patients. Twit Text FOAVip Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease ????Curr Hepatol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32837825 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32837825 #FOAvip English Wikipedia <ref>{{Cite pmid|32837825}}</ref> Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease #MMPMID32837825 Tufoni M; Baldassarre M; Zaccherini G; Antognoli A; Caraceni P Curr Hepatol Rep 2020[]; 19 (3): 147-158 PMID32837825show ga PURPOSE OF REVIEW: Albumin administration is recommended to prevent or treat specific complications of decompensated cirrhosis based on its capacity to expand plasma volume. However, the molecule also has many other biological properties that are unrelated to the oncotic activity. The purpose of this review is to examine the hemodynamic and systemic effects of albumin administration in patients with decompensated cirrhosis. RECENT FINDINGS: Besides plasma expansion, albumin appears to act against inflammation, facilitate immunocompetence, and improve cardiac and endothelial function, thus antagonizing critical steps in the pathophysiological cascade underlying decompensated cirrhosis. SUMMARY: Increasing knowledge of the pathophysiological mechanisms of the disease, as well the pleiotropic properties of the molecule, provides the rationale for considering albumin as a multi-target disease-modifying agent in decompensated cirrhosis. Both oncotic and non-oncotic properties likely concur with the clinical benefits of long-term albumin administration recently demonstrated in these patients. äHemodynamic and Systemic Effects of Albumin in Patients with Advanced (epmc).pdf DeepDyve Pubget Overpricing